Corbus Pharmaceuticals (NASDAQ:CRBP) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Trading Down 3.3 % Shares of Corbus Pharmaceuticals stock opened at $5.41 on Friday. The company’s 50-day moving average price is $5.17 and […]
More Stories
3i Group (LON:III) Sets New 52-Week High – Time to Buy?
3i Group (LON:III – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday ....
BMO REX MicroSectors FANG Index 3X Leveraged ETN (NYSEARCA:FNGU) Shares Down 3.4% – Here’s What Happened
Shares of BMO REX MicroSectors FANG Index 3X Leveraged ETN (NYSEARCA:FNGU – Get Free Report) fell 3.4% during trading on...
Sweetgreen (NYSE:SG) Shares Down 2.1% – Here’s What Happened
Shares of Sweetgreen, Inc. (NYSE:SG – Get Free Report) fell 2.1% during trading on Wednesday . The stock traded as...
Zebra Technologies (NASDAQ:ZBRA) Hits New 12-Month High – Time to Buy?
Zebra Technologies Co. (NASDAQ:ZBRA – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday ....
IDT (NYSE:IDT) Sets New 12-Month High – Time to Buy?
IDT Co. (NYSE:IDT – Get Free Report) shares reached a new 52-week high on Wednesday . The stock traded as...
MetLife Investment Management LLC Reduces Position in Exxon Mobil Co. (NYSE:XOM)
MetLife Investment Management LLC decreased its holdings in Exxon Mobil Co. (NYSE:XOM – Free Report) by 3.4% in the 3rd...